1. Home
  2. AIMD vs DOMH Comparison

AIMD vs DOMH Comparison

Compare AIMD & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • DOMH
  • Stock Information
  • Founded
  • AIMD 1984
  • DOMH 1967
  • Country
  • AIMD United States
  • DOMH United States
  • Employees
  • AIMD N/A
  • DOMH N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIMD Health Care
  • DOMH Health Care
  • Exchange
  • AIMD Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • AIMD 8.5M
  • DOMH 8.8M
  • IPO Year
  • AIMD N/A
  • DOMH N/A
  • Fundamental
  • Price
  • AIMD $0.74
  • DOMH $11.94
  • Analyst Decision
  • AIMD
  • DOMH
  • Analyst Count
  • AIMD 0
  • DOMH 0
  • Target Price
  • AIMD N/A
  • DOMH N/A
  • AVG Volume (30 Days)
  • AIMD 380.6K
  • DOMH 4.0M
  • Earning Date
  • AIMD 03-07-2025
  • DOMH 03-31-2025
  • Dividend Yield
  • AIMD N/A
  • DOMH N/A
  • EPS Growth
  • AIMD N/A
  • DOMH N/A
  • EPS
  • AIMD N/A
  • DOMH N/A
  • Revenue
  • AIMD $40,633.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • AIMD N/A
  • DOMH N/A
  • Revenue Next Year
  • AIMD N/A
  • DOMH N/A
  • P/E Ratio
  • AIMD N/A
  • DOMH N/A
  • Revenue Growth
  • AIMD N/A
  • DOMH 1117.50
  • 52 Week Low
  • AIMD $0.40
  • DOMH $0.83
  • 52 Week High
  • AIMD $3.10
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 59.44
  • DOMH 82.78
  • Support Level
  • AIMD $0.57
  • DOMH $6.31
  • Resistance Level
  • AIMD $0.77
  • DOMH $13.58
  • Average True Range (ATR)
  • AIMD 0.06
  • DOMH 1.72
  • MACD
  • AIMD -0.00
  • DOMH 1.00
  • Stochastic Oscillator
  • AIMD 68.48
  • DOMH 86.16

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: